Priapism in Boys and Young Men: Incidence and Prevalence

男孩和年轻男性阴茎异常勃起:发病率和患病率

基本信息

  • 批准号:
    7407404
  • 负责人:
  • 金额:
    $ 18.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

The primary goal of this study is to conduct a comprehensive investigation of priapism in boys and young men with sickle cell disease (SCD). As such, it represents the initial step toward defining an effective way to manage priapism, and to reduce the frequency of impotence that is its major complication in adult males with SCD. The aims of this proposal are: 1) to conduct a Iongitudinal cohort study in order to define the incidence of priapism in relationship to the physical and hormonal developmental stages of puberty and early maturity, to explore the relationship between priapism and psychological adjustment; and 2) to conduct a pilot, placebo-controlled intervention trial in which the ability of pseudoephedrine to prevent priapism will be evaluated. The first stage of this proposal involves an observational study that will be open to all boys and young men with SCD between the ages of 7 -29 years. They will keep daily records of the occurrence of priapism, and will be admitted every 6 months for an intensive evaluation of physical growth, genital pubertal stage, body composition, bone age, gonadotropins, testosterone, insulin-like growth factor and nocturnal penile tumescence. During these admissions, the participants will also complete several psychological assessments. Data from this phase will be used to identify the association (if any) between priapism and pubertal stage, gonadotropin levels, and testosterone concentration. The data will also determine if there is a relationship between priapism and psychological adjustment. The second stage of this proposal will seek to enroll those individuals who are found to have qualifying episodes of priapism on to a randomized, double-blinded, placebo-controlled clinical trial of pseudoephedrine. The purpose of this pilot study is to determine whether pseudoephedrine is able to prevent episodes of priapism. During this trial, each participant will continue to keep the same daily journal. In addition, each participant will be admitted at the beginning and end of the trial to complete the same physical, hormonal and psychological assessments as were performed in the observational phase. The outcome measures of the prevention trial will be the occurrence of priapism, duration of priapism and the interval between episodes of priapism. In addition, physical growth, secondary sexual development, body composition and psychological adjustment will be compared between the treatment arms. The data collected will establish the feasibility of certain key methods, and will provide estimates of rates, standard deviations, median time-to-event. These results, which are absolutely essential before a large scale treatment trial can be planned, will provide the biological and statistical background for future work in this field.
本研究的主要目的是对患有镰状细胞病(SCD)的男孩和年轻男性阴茎勃起功能障碍进行全面调查。因此,它代表了定义一种有效的方法来管理阴茎勃起,并减少阳痿的频率的第一步,阳痿是成年男性SCD的主要并发症。本研究的目的是:1)通过纵向队列研究,明确阴茎勃起的发生率与青春期和早熟生理和激素发育阶段的关系,探讨阴茎勃起与心理调节的关系;2)进行试点,安慰剂控制

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RUPA C REDDING-LALLINGER其他文献

RUPA C REDDING-LALLINGER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RUPA C REDDING-LALLINGER', 18)}}的其他基金

PRIAPISM IN BOYS AND MEN: INCIDENCE AND PREVENTION
男孩和男性阴茎异常勃起:发病率和预防
  • 批准号:
    7716785
  • 财政年份:
    2008
  • 资助金额:
    $ 18.64万
  • 项目类别:
CLINICAL TRIAL: SILENT CEREBRAL INFARCT TRANSFUSION TRIAL (SIT TRIAL)
临床试验:无声脑梗死输血试验(SIT 试验)
  • 批准号:
    7716782
  • 财政年份:
    2008
  • 资助金额:
    $ 18.64万
  • 项目类别:
PRIAPISM IN BOYS AND MEN: INCIDENCE AND PREVENTION
男孩和男性阴茎异常勃起:发病率和预防
  • 批准号:
    7625562
  • 财政年份:
    2006
  • 资助金额:
    $ 18.64万
  • 项目类别:
SILENT CEREBRAL INFARCT TRANSFUSION TRIAL (SIT TRIAL)
无声脑梗死输血试验(静坐试验)
  • 批准号:
    7625559
  • 财政年份:
    2006
  • 资助金额:
    $ 18.64万
  • 项目类别:
SILENT CEREBRAN INFARCT TRANSFUSION TRIAL (SIT TRIAL)
无声脑梗死输血试验(静坐试验)
  • 批准号:
    7377497
  • 财政年份:
    2005
  • 资助金额:
    $ 18.64万
  • 项目类别:
PRIAPISM IN BOYS AND MEN: INCIDENCE AND PREVENTION
男孩和男性阴茎异常勃起:发病率和预防
  • 批准号:
    7377502
  • 财政年份:
    2005
  • 资助金额:
    $ 18.64万
  • 项目类别:
SILENT CEREBRAN INFARCT TRANSFUSION TRIAL (SIT TRIAL)
无声脑梗死输血试验(静坐试验)
  • 批准号:
    7200307
  • 财政年份:
    2004
  • 资助金额:
    $ 18.64万
  • 项目类别:
THE AS GENOTYPE, OTHER RBC CONDITIONS, AND FERTILITY
AS 基因型、其他红细胞状况和生育力
  • 批准号:
    3050118
  • 财政年份:
    1986
  • 资助金额:
    $ 18.64万
  • 项目类别:
THE AS GENOTYPE, OTHER RBC CONDITIONS, AND FERTILITY
AS 基因型、其他红细胞状况和生育力
  • 批准号:
    3050119
  • 财政年份:
    1986
  • 资助金额:
    $ 18.64万
  • 项目类别:

相似海外基金

How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y004841/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.64万
  • 项目类别:
    Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
  • 批准号:
    BB/Y001427/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.64万
  • 项目类别:
    Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y005414/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.64万
  • 项目类别:
    Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 18.64万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 18.64万
  • 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
  • 批准号:
    10821599
  • 财政年份:
    2023
  • 资助金额:
    $ 18.64万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10841832
  • 财政年份:
    2023
  • 资助金额:
    $ 18.64万
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    $ 18.64万
  • 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
  • 批准号:
    10741261
  • 财政年份:
    2022
  • 资助金额:
    $ 18.64万
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    $ 18.64万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了